1 |
Calvet X, Villoria A. Esophageal diseases: gastroesophageal reflux disease and Barrett′s esophagus[J]. Gastroenterol Hepatol, 2012, 35: 26-34.
|
2 |
Liu X, Li M, Xu D, et al.Prevalence and clinical importance of gastroesophageal reflux in Chinese patients with systemic sclerosis[J]. Clin Exp Rheumatol, 2012, 30(2 Suppl 71): 60-66.
|
3 |
潘国宗,许国铭,郭慧平,等.北京上海胃食管反流症状的流行病学调查[J].中华消化杂志,1999,19(4):223-225.
|
4 |
中华医学会消化病学分会胃肠动力学组.胃食管反流病治疗共识意见[J].中华消化杂志,2007,27(10):689.
|
5 |
Kahrilas PJ.Esophageal motor disorders in terms of high-resolution esophageal pressure topography[J]Gastroenterol, 2010, 105(5): 981-987.
|
6 |
邹磊,蒋绚,赵景涛.食管下括约肌长度测定的临床意义[J].北京医科大学学报,1999,31(1):90-92.
|
7 |
孙晓红,柯美云,王智凤,等.膈脚屏障及食管体部清除功能在胃食管反流中的作用[J].中国医学科学院学报,2002,24(3):289-293.
|
8 |
Lee J, Anggiansah A, Anggiansah R, et al.Effects of age on the gastroesophageqal junction, Esophageal motility, and reflux disease [J]. Clin Gastroenterol Hepatol, 2007, 5(12): 1392-1398.
|
9 |
Simren M, Silny J, Holloway R, et al.Relevance of ineffective oesophageal motility during esophageal acid clearance[J]. Gut, 2003, 52(6): 784-790.
|
10 |
Orr WC, Elsenbruch S, Harnish MJ, et al.Proximal migration of esophageal acid perfusions during waking and sleep[J]. Am J Gastroenterol, 2000, 95(1): 37-42.
|
11 |
Wu JC.Gastroesophageal reflux disease: an Asian perspective[J]. J Gastroenterol Hepatol, 2008, 23(12): 1785-1793.
|
12 |
Devault K, Castell DO, American College of Gastroentroiogy.Update guidelines for the diagnosis and treatment of gastroesophageal reflux disease[J]. Am J Gastroenterol, 2005, 100(1): 190-200.
|
13 |
闫斌,刘庆森,黄启阳,等.原发性小肠淋巴管扩张症1例并文献复习[J].胃肠病学和肝病学杂志,2013,22(5):471-472.
|
14 |
张玉琴,巴亚斯古楞,任建林.胃食管反流病的危险因素以及相关疾病的研究概况[J].胃肠病学,2012,17(5):307-310.
|
15 |
Ang D, Blondeau K, Sifrim D, et al.The spectrum of motor function abnormalities in gastroesophageal reflux disease and Barrett′s esophagus[J]. Digestion, 2009, 79(3): 158-168.
|
16 |
邹方明,庄则豪.胃食管反流病发病机制研究进展[J/CD].中华临床医师杂志:电子版,2011,5(23):7035-7037.
|
17 |
Jovov B, Que J, Tobey NA, et al.Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease[J]. Am J Gastroenterol, 2011, 106(6): 1039-1047.
|
18 |
Ashktorab H, Entezari O, Nouraie M, et al.Helicobacter pylori Protection Against Reflux Esophagitis[J]. Dig Dis Sci, 2012, 57(11): 2924-2928.
|
19 |
Wu JC, Cheung CM, Wong VW, et al.Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis[J]. Clin Gastroenterol Hepatol, 2007, 5(6): 690-695.
|
20 |
Rodrigues Jr L, Faria CM, Geocze S, et al.Helicobacter pylorieradication does not influence gastroesophageal reflux disease: aprospective, parallel, randomized, open-label, controlled trial[J]. Arq Gastroenterol, 2012, 49(1): 56-63.
|
21 |
Mohammed I, Cherkas LF, Riley SA, et al.Genetic influences in gastro-oesophageal reflux disease: a twin study[J]. Gut, 2003, 52(8): 1085-1089.
|
22 |
Cheng HH, Chang CS, Wang HJ, et al.Interleukin-1beta and-10 polymorphisms influence erosive reflux esophagitis and gastritis in Taiwanese patients[J]. Gastroenterol Hepatol, 2010, 25(8): 1443-1451.
|
23 |
房俊,杨晓俊,喻春钊,等.胃食管反流病发病机制研究进展[J].中华普通外科学文献,2013,7(3):217-221.
|
24 |
Takenaka R, Matsuno O, Kitajima K, et al.The use of frequency scale for the symptoms of GERD in assessment of gastro-oesophageal reflex symptoms in asthma[J]. Allergol Immunopathol(Madr), 2010, 38(1): 20-24.
|
25 |
刘诗.改变生活方式在治疗胃食管反流病的作用[J].临床消化病杂志,2008,20(1):8.
|
26 |
杨建,刘梅,何键,等.胃食管反流病研究进展[J].检验医学与临床,2012,9:1752-1754.
|
27 |
中华医学会消化病学分会胃肠动力学组.胃食管反流病治疗共识意见(2007年西安)[J].中华消化杂志,2007,27(10):689-690.
|
28 |
Garcia Rodriguez LA, Lagergren J, Lindblad M. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK[J]. Gut, 2006, 55(11): 1538-1544.
|
29 |
王炘.胃食管反流病与幽门螺杆菌感染的关系探讨[J].胃肠病学和肝病学杂志,2010,19(1):74-77.
|
30 |
孙晓红.胃食管反流病的病理生理机制[J].中华内科杂志,2011,50(8):630-632.
|
31 |
Lehmann A. Novel treatments of GERD: focus on the lower esophageal sphincter[J]. Eur Rev Med Pharmacol Sci, 2008, 12(suppl 1): 103-105.
|
32 |
李军,李严严,张丽娟,等.老年胃食管反流病患者心理健康评估和干预157例[J].世界华人消化杂志,2008,16(15):1685-1687.
|
33 |
Awad RA.Medical and surgical management of esophageal and gastric motor dysfunction[J]. Minerva Gastroenterol Dietol, 2012, 58(3): 227-238.
|
34 |
Granero Cendón R, Ruiz Hierro C, Garrido Pérez JI, et al.Evaluation of quality of life in patients operated on for gastroesophageal reflux in the pediatric age[J]. Cir Pediatr, 2012, 25(2): 82-86.
|
35 |
Lee WJ, Chan CP, Wang BY.Recent advances in laparoscopic surgery[J]. Asian J Endosc Surgery, 2013, 6(1): 1-8.
|
36 |
杨云生,令狐恩强,孙刚,等.胃镜下腔内折叠术治疗胃食管反流病[J].中华消化内镜杂志,2002,19(5):265-267.
|
37 |
Amarasiri DL, Pathmeswaran A, de Silva HJ, et al.Response of the airways and autonomic nervous system to acid perfusion of the esophagus in patients with asthma: a laboratory study[J]. BMC Pulm Med, 2013, 13(1): 33.
|
38 |
Galmiche JP, Hatlebakk J, Attwood S, et al.Laparoscopic Antireflux Surgery vs Esomeprazole Treatment for Chronic GERD The LOTUS Randomized Clinical Trial[J]. JAMA, 2011, 305(19): 1969-1977.
|
39 |
Anvari M, Allen C, Marshall J, et al.A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease(GERD): 3-year outcomes[J]. Surg Endosc, 2011, 25(8): 2547-2554.
|
40 |
Goeree R, Hopkins R, Marshall JK, et al.Cost-Utility of Laparoscopic Nissen Fundoplication versus Proton Pump Inhibitors for Chronic and Controlled Gastroesophageal Reflux Disease: A 3-Year Prospective Randomized Controlled Trial and Economic Evaluation[J]. Value Health, 2010, 9(4): 263-273.
|
41 |
Fiocca R, Mastracci L, Engström C, et al.Long-Term Outcome of Microscopic Esophagitis in Chronic GERD Patients Treated With Esomeprazole or Laparoscopic Antireflux Surgery in the LOTUS Trial[J]. Am J Gastroenterol, 2010, 105(5): 1015-1023.
|
42 |
Epstein D, Bojke L, Sculpher MJ.Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study[J]. BMJ, 2009, 338: b2576.
|
43 |
Grant AM, Wileman SM, Ramsay CR, et al.Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial[J]. BMJ, 2008, 337: a2664.
|
44 |
Attwood SE, Lundell L, Hatlebakk JG, et al.Medical or Surgical Management of GERD Patients with Barrett′s Esophagus: The LOTUS Trial 3-Year Experience[J]. J Gastrointest Surg, 2008, 12(10): 1646-1655.
|
45 |
Lundell L, Attwood S, Ell C, et al.Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial[J]. Gut, 2008, 57(9): 1207-1213.
|
46 |
Anvari M, Allen C, Marshall J, et al.A randomized controlled trial of laparoscopic nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: One-year follow-up[J]. Surg Innor, 2006, 13(4): 238-249.
|
47 |
Mehta S, Bennett J, Mahon D, et al.Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up[J]. J Gastrointes Surg, 2006, 10(9): 1312-1317.
|
48 |
Olberg P, Johannessen R, Johnsen G, et al.Long-term outcome of surgically and medically treated patients with gastroesophageal reflux disease: A matched-pair follow-up study[J]. Seand J Gastroenterol, 2005, 40(10): 264-274.
|
49 |
Mahon D, Rhodes M, Decadt B, et al.Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux[J]. Br J Surg, 2005, 92(6): 695-699.
|
50 |
Cookson R, Flood C, Koo B, et al.Short-term cost effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton-pump inhibitor maintenance for gastro-oesophageal reflux disease[J]. Br J Surg, 2005, 92(6): 700-706.
|